Your Health, We Care
Based on the results of the COLUMBUS clinical trial, Binimetinib was first approved for marketing in the United States on June 27, 2018.
Before starting treatment, it is necessary to identify the presence of BRAF V600E or V600K mutations in the tumor sample.
On October 12, 2023, Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Encorafenib in combination with Binimetinib for the treatment of adult pati···【more】
Article source：Lucius LaosRelease date：2026-03-05Recommended：22
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
